Validation of the modified Microlife blood pressure monitor in patients with paroxysmal atrial fibrillation.
Nina HuppertzGregory Y H LipDeirdre A LanePublished in: Clinical research in cardiology : official journal of the German Cardiac Society (2019)
The Microlife WatchBPO3 AFIB device has an acceptable diagnostic accuracy to detect PAF; however, movement artefact affects the accuracy of the readings. This modified BP monitor may potentially be useful as a screening tool for AF in patients at high risk of developing stroke.
Keyphrases
- atrial fibrillation
- blood pressure
- catheter ablation
- oral anticoagulants
- left atrial
- left atrial appendage
- direct oral anticoagulants
- heart failure
- percutaneous coronary intervention
- hypertensive patients
- metabolic syndrome
- blood glucose
- insulin resistance
- coronary artery disease
- subarachnoid hemorrhage
- blood brain barrier
- mitral valve
- weight loss